Laura Zamorano
Laura Zamorano
Researcher Son Espases Hospital
Verified email at ssib.es
Title
Cited by
Cited by
Year
β-Lactam resistance response triggered by inactivation of a nonessential penicillin-binding protein
B Moya, A Dötsch, C Juan, J Blázquez, L Zamorano, S Haussler, A Oliver
PLoS Pathog 5 (3), e1000353, 2009
2402009
Genetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clones
G Cabot, AA Ocampo-Sosa, MA Domínguez, JF Gago, C Juan, F Tubau, ...
Antimicrobial agents and chemotherapy 56 (12), 6349-6357, 2012
202*2012
Overexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolates from bloodstream infections: prevalence and impact on resistance in a Spanish multicenter study
G Cabot, AA Ocampo-Sosa, F Tubau, MD Macia, C Rodríguez, B Moya, ...
Antimicrobial agents and chemotherapy 55 (5), 1906-1911, 2011
1782011
Pseudomonas aeruginosa ceftolozane-tazobactam resistance development requires multiple mutations leading to overexpression and structural modification of AmpC
G Cabot, S Bruchmann, X Mulet, L Zamorano, B Moyà, C Juan, ...
Antimicrobial agents and chemotherapy 58 (6), 3091-3099, 2014
1602014
Evolution of Pseudomonas aeruginosa antimicrobial resistance and fitness under low and high mutation rates
G Cabot, L Zamorano, B Moyà, C Juan, A Navas, J Blázquez, A Oliver
Antimicrobial agents and chemotherapy 60 (3), 1767-1778, 2016
1292016
Prevalence and molecular epidemiology of acquired AmpC β-lactamases and carbapenemases in Enterobacteriaceae isolates from 35 hospitals in Spain
E Miró, J Agüero, MN Larrosa, A Fernández, MC Conejo, G Bou, ...
European journal of clinical microbiology & infectious diseases 32 (2), 253-259, 2013
1252013
Prospective multicenter study of carbapenemase-producing Enterobacteriaceae from 83 hospitals in Spain reveals high in vitro susceptibility to colistin and meropenem
J Oteo, A Ortega, R Bartolomé, G Bou, C Conejo, M Fernández-Martínez, ...
Antimicrobial agents and chemotherapy 59 (6), 3406-3412, 2015
1232015
Pan-β-lactam resistance development in Pseudomonas aeruginosa clinical strains: molecular mechanisms, penicillin-binding protein profiles, and binding affinities
B Moyá, A Beceiro, G Cabot, C Juan, L Zamorano, S Alberti, A Oliver
Antimicrobial agents and chemotherapy 56 (9), 4771-4778, 2012
1212012
Influence of Virulence Genotype and Resistance Profile in the Mortality of Pseudomonas aeruginosa Bloodstream Infections
C Peña, G Cabot, S Gómez-Zorrilla, L Zamorano, A Ocampo-Sosa, ...
Clinical Infectious Diseases 60 (4), 539-548, 2015
1182015
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum β-lactamases GES-1 and GES-5 in Spain
E Viedma, C Juan, J Acosta, L Zamorano, JR Otero, F Sanz, F Chaves, ...
Antimicrobial agents and chemotherapy 53 (11), 4930-4933, 2009
1122009
Metallo-β-lactamase-producing Pseudomonas putida as a reservoir of multidrug resistance elements that can be transferred to successful Pseudomonas aeruginosa clones
C Juan, L Zamorano, A Mena, S Albertí, JL Pérez, A Oliver
Journal of antimicrobial chemotherapy 65 (3), 474-478, 2010
1102010
Alterations of OprD in carbapenem-intermediate and-susceptible strains of Pseudomonas aeruginosa isolated from patients with bacteremia in a Spanish multicenter study
AA Ocampo-Sosa, G Cabot, C Rodríguez, E Roman, F Tubau, MD Macia, ...
Antimicrobial agents and chemotherapy 56 (4), 1703-1713, 2012
1052012
Activity of a new cephalosporin, CXA-101 (FR264205), against β-lactam-resistant Pseudomonas aeruginosa mutants selected in vitro and after antipseudomonal treatment of …
B Moya, L Zamorano, C Juan, JL Pérez, Y Ge, A Oliver
Antimicrobial agents and chemotherapy 54 (3), 1213-1217, 2010
1052010
Affinity of the new cephalosporin CXA-101 to penicillin-binding proteins of Pseudomonas aeruginosa
B Moya, L Zamorano, C Juan, Y Ge, A Oliver
Antimicrobial agents and chemotherapy 54 (9), 3933-3937, 2010
1002010
Biological markers of Pseudomonas aeruginosa epidemic high-risk clones
X Mulet, G Cabot, AA Ocampo-Sosa, MA Domínguez, L Zamorano, ...
Antimicrobial agents and chemotherapy 57 (11), 5527-5535, 2013
972013
Activity of a new antipseudomonal cephalosporin, CXA-101 (FR264205), against carbapenem-resistant and multidrug-resistant Pseudomonas aeruginosa clinical strains
C Juan, L Zamorano, JL Pérez, Y Ge, A Oliver, ...
Antimicrobial agents and chemotherapy 54 (2), 846-851, 2010
842010
Genomics and susceptibility profiles of extensively drug-resistant Pseudomonas aeruginosa isolates from Spain
E del Barrio-Tofiño, C López-Causapé, G Cabot, A Rivera, N Benito, ...
Antimicrobial agents and chemotherapy 61 (11), 2017
822017
Deciphering the resistome of the widespread Pseudomonas aeruginosa sequence type 175 international high-risk clone through whole-genome sequencing
G Cabot, C López-Causapé, AA Ocampo-Sosa, LM Sommer, ...
Antimicrobial agents and chemotherapy 60 (12), 7415-7423, 2016
722016
Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain
ZR Palacios-Baena, J Oteo, C Conejo, MN Larrosa, G Bou, ...
Journal of Infection 72 (2), 152-160, 2016
692016
NagZ inactivation prevents and reverts β-lactam resistance, driven by AmpD and PBP 4 mutations, in Pseudomonas aeruginosa
L Zamorano, TM Reeve, L Deng, C Juan, B Moyá, G Cabot, DJ Vocadlo, ...
Antimicrobial agents and chemotherapy 54 (9), 3557-3563, 2010
602010
The system can't perform the operation now. Try again later.
Articles 1–20